Singapore group will develop 'most promising' Ebola vaccine

PARIS: A Singapore-based organisation announced on Thursday (Jul 30) it will develop an Ebola vaccine dubbed the "most promising" to fight back against a deadly outbreak in the Democratic Republic of Congo.Nearly 1,500 people have died in the conflict-wracked African country from the Bundibugyo strain of Ebola, for which there are no vaccines or treatments.But there are several different efforts racing to develop a vaccine for the previously rare strain in the hope of stemming the escalating outbreak.World Health Organization experts have said a single-dose shot based on the rVSV platform is the "most promising" candidate. This is because it uses the same platform as the only officially licensed Ebola vaccine Ervebo, which targets a different strain called Zaire.The Singapore-based Hillema